TNF Pharmaceuticals, Inc.
TNFA
$0.0642
-$0.0109-14.51%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.81M | 5.88M | 8.52M | 10.64M | 13.07M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.34M | 898.30K | 893.70K | 1.39M | 1.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.15M | 6.78M | 9.41M | 12.03M | 14.36M |
|
|
|||||
| Total Current Assets | 5.15M | 6.78M | 9.41M | 12.03M | 14.36M |
| Net Property, Plant & Equipment | -- | 2.70K | 10.60K | 18.30K | 25.80K |
| Long-term Investments | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Goodwill | 10.50M | 10.50M | 10.50M | 10.50M | 10.50M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 17.15M | 18.78M | 21.42M | 24.04M | 26.38M |
|
|
|||||
| Total Accounts Payable | 2.68M | 2.17M | 2.52M | 3.71M | 4.09M |
| Total Accrued Expenses | -- | 428.70K | 386.70K | 455.20K | 524.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 2.70K | 10.60K | 18.30K | 25.80K |
| Total Finance Division Other Current Liabilities | 2.87M | 2.34M | 3.79M | 2.81M | 1.14M |
| Total Other Current Liabilities | 2.87M | 2.34M | 3.79M | 2.81M | 1.14M |
| Total Current Liabilities | 5.55M | 4.94M | 6.70M | 6.99M | 5.78M |
|
|
|||||
| Total Current Liabilities | 5.55M | 4.94M | 6.70M | 6.99M | 5.78M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 20.22M |
| Total Liabilities | 5.55M | 4.94M | 6.70M | 6.99M | 26.00M |
|
|
|||||
| Common Stock & APIC | 138.98M | 139.62M | 138.78M | 142.64M | 123.28M |
| Retained Earnings | -133.85M | -131.08M | -129.14M | -126.00M | -123.32M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.13M | 8.55M | 9.65M | 16.63M | -46.70K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 6.47M | 5.30M | 5.07M | 422.20K | 429.00K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 6.47M | 5.30M | 5.07M | 422.20K | 429.00K |
|
|
|||||
| Total Common Equity | 5.13M | 8.55M | 9.65M | 16.63M | -46.70K |
| Total Preferred Equity | 6.47M | 5.30M | 5.07M | 422.20K | 429.00K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.60M | 13.84M | 14.72M | 17.06M | 382.30K |
|
|
|||||